What does CUSIP 87650L103 represent in this 13F holders report?

CUSIP 87650L103 is the security identifier for TARS - Tarsus Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in Q1 2022?

50 institutional investors reported TARS - Tarsus Pharmaceuticals, Inc. - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)

CUSIP: 87650L103

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock
Total 13F shares: 13,210,299
Total 13F value: $222,212,113
Share change: -1,281,157
SEC-reported price per share: $16.82
Number of holders: 50
Value change: -$29,618,514
Number of buys: 17
Number of sells: 20
Shares outstanding: 42,282,321

Security key

87650L103

Report period

Q1 2022

Institutions

Top holders

TARS full security history Ownership snapshot Full 13F holder table Tarsus Pharmaceuticals, Inc. SEC filings Tarsus Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Vivo Capital, LLC

Disclosed value leader

Vivo Capital, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F 3/4/5 Lead comparable stake: 7.1% Showing 1-6 of 15 holder rows.

Quick read

Vivo Capital, LLC leads the comparable SEC ownership view at 7.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Vivo Capital, LLC's linked filing trail.

Comparable ownership Top 5

Vivo Capital, LLC 7.1%

RTW INVESTMENTS, LP 4.8%

FRAZIER MANAGEMENT LLC 3.4%

Cormorant Asset Management, LP 3.3%

PERCEPTIVE ADVISORS LLC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Vivo Capital, LLC	13F Company 13F	7.1%	$67,215,000 2,987,331 shares	—	31 Dec 2021
RTW INVESTMENTS, LP	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	4.8%	$45,306,000 2,013,601 shares	—	31 Dec 2021
FRAZIER MANAGEMENT LLC	13F Company 13F	3.4%	$31,886,000 1,417,157 shares	—	31 Dec 2021
Cormorant Asset Management, LP	13F Company 13F	3.3%	$31,575,000 1,403,331 shares	—	31 Dec 2021
PERCEPTIVE ADVISORS LLC	13F Company 13F	3.1%	$29,169,000 1,296,416 shares	—	31 Dec 2021
TimesSquare Capital Management, LLC	13F Company 13F	1.6%	$14,868,000 660,800 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

13,210,299

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %